More stories
Op-Ed: Psychedelics in Practice: What the State Programs Are Teaching Us
Here at Psychedelic Alpha, we spend a great deal of time writing about the pursuit of regulatory approval for psychedelic medicines, with a key...
The Psychedelic News Feed: January 05 – 11, 2026
This is an archived version of our Psychedelic News Feed. Explore the live Feed and receive a weekly digest to your inbox by joining...
From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to the European Public
Théo was stuck. At twenty-something, he had everything that should have made sense on paper: a political science degree, a job in the European...
Psychedelic Medicine at the Edge of Science and Spirit
In recent years, something quietly disruptive has been occurring inside the world of modern psychedelic medicine. At ketamine-assisted therapy clinics, we are hearing about...
Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH...
Welcome to our first Psychedelic Bulletin of 2026! It’s been a very busy start to the year, but fret not: this Bulletin will get...
Manvir Singh: Shamanism, the Timeless Religion
Manvir Singh PhD joins us to unpack what shamanism means and why the term matters now. Singh is an anthropologist and author of Shamanism:...
2025 Year in Review: Future(s) & Open Questions (Video)
Watch the third and final video in our 2025 Year in Review series. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor...
2025 Year in Review: 10 Standout Stories in Psychedelics
Before we get started in earnest with our 2026 coverage, I’m taking a moment to look back at the 150-odd pieces of content we...
2025 Year in Review: Looking Ahead to Psychedelics in 2026 (Video)
Watch the second video in our 2025 Year in Review series. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman,...
Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking
Oli Genn-Bash (Brighton, UK) joins Joe Moore for a grounded conversation on the boom in functional mushrooms and why the category may be moving...
Chronic Pain, Illicit Markets, and a Preventable Pipeline to Addiction
Chronic pain is one of the most common and least discussed entry points into substance-related harm in the United States. Long before heroin or...
Year in Review: Psychedelics in 2025 (Video)
Watch the first video in our 2025 Year in Review series. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman,...
